1. Home
  2. FFA vs SPRC Comparison

FFA vs SPRC Comparison

Compare FFA & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Enhanced Equity Income Fund

FFA

First Trust Enhanced Equity Income Fund

HOLD

Current Price

$22.07

Market Cap

429.4M

Sector

Finance

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$1.47

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFA
SPRC
Founded
2004
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.4M
4.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FFA
SPRC
Price
$22.07
$1.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.1K
1.3M
Earning Date
01-01-0001
03-23-2026
Dividend Yield
6.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,306,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
187.98
52 Week Low
$15.84
$1.25
52 Week High
$19.30
$37.59

Technical Indicators

Market Signals
Indicator
FFA
SPRC
Relative Strength Index (RSI) 61.29 35.79
Support Level $21.87 $1.25
Resistance Level $22.10 $1.52
Average True Range (ATR) 0.16 0.12
MACD 0.04 0.04
Stochastic Oscillator 98.67 42.76

Price Performance

Historical Comparison
FFA
SPRC

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: